In addition, we see some increased risk of pancreatic cancer associated with the use of insulin and the use of insulin secretagogues.
另外，我们发现运用胰岛素和胰岛素促分泌剂有可能导致胰腺癌的危险。
2
In contrast, diabetics who had taken insulin or insulin secretagogues had a 4.99 - and 2.52-fold increased risk for the disease, respectively, compared with never users.
对比从未使用胰岛素或胰岛素促泌素糖尿病患者，使用者分别增加了4.99和2.52倍的患病风险。
3
Insulin secretagogues presently is not only a kind of major oral hypoglycemic drugs but also the first-line treatment for non-obese and obese type 2 diabetic mellitus(T2DM).